iX Biopharma Ltd 2019 Annual Report
Company: iX Biopharma Ltd
Sector: Manufacturing
Country: Singapore
Year: 2019
Type: Annual Report
Pages: 136
The report describes FY2019 as a year of commercial and operational expansion, with total continuing-operations revenue rising to 671 $'000 from 246 $'000 and Entity distribution expanding from 25 to 178 retail stores. The company also invested in manufacturing capacity and divested its chemical testing laboratory to focus on its core pharmaceutical and nutraceutical businesses. Its sustainability statement identifies energy as a material topic and notes that the inaugural Sustainability Report was prepared with reference to GRI Standards.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.